This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 1. To evaluate the effect of Darbepoietin on reticulocytes and hematocrits. 2. To estimate the rates of adverse events among very low birth weight (VLBW) infants who receive 1 of 3 doses of Darbepoietin.
Showing the most recent 10 out of 568 publications